A detailed history of Neos Investment Management LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 78,883 shares of DAWN stock, worth $1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
78,883
Previous 64,853 21.63%
Holding current value
$1 Million
Previous $894 Million 22.96%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$12.72 - $16.03 $178,461 - $224,900
14,030 Added 21.63%
78,883 $1.1 Billion
Q2 2024

Aug 14, 2024

BUY
$12.03 - $17.69 $245,772 - $361,406
20,430 Added 45.99%
64,853 $894 Million
Q1 2024

May 13, 2024

BUY
$13.56 - $17.46 $392,100 - $504,873
28,916 Added 186.47%
44,423 $734 Million
Q4 2023

Feb 13, 2024

BUY
$9.68 - $15.37 $150,107 - $238,342
15,507 New
15,507 $226 Million

Others Institutions Holding DAWN

About Day One Biopharmaceuticals, Inc.


  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $932M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.